N-((S)-1-(((R)-1-Hydroxy-3-Methylbutyl)aMino)-1-oxo-3-phenylpropan-2-yl)pyrazine-2-carboxaMide
|
|
|
- CAS-Nr.
- 289472-78-2
- Englisch Name:
- N-((S)-1-(((R)-1-Hydroxy-3-Methylbutyl)aMino)-1-oxo-3-phenylpropan-2-yl)pyrazine-2-carboxaMide
- Synonyma:
- Bortezomib USP IMP I;Bortezomib USP Impurity I;Bortezomib (EP) Impurity E;SR-Isomer, Bortezomib Impurity E;Bortezomib USP Related Compoud I;Bortezomib Impurity 2 (S,R-Isomer);Bortezomib (1S,2R) Isomer Impurity;(R)-Hydroxy Des(boric Acid) BortezoMib;Bortezomib impurity 5/Bortezomib EP Impurity E;(S,R)-Bortezomib Hydroxyisopentyl Amide Analog
- CBNumber:
- CB32661929
- Summenformel:
- C19H24N4O3
- Molgewicht:
- 356.42
- MOL-Datei:
- 289472-78-2.mol
|
N-((S)-1-(((R)-1-Hydroxy-3-Methylbutyl)aMino)-1-oxo-3-phenylpropan-2-yl)pyrazine-2-carboxaMide Eigenschaften
- Siedepunkt:
- 672.0±55.0 °C(Predicted)
- Dichte
- 1.199±0.06 g/cm3(Predicted)
- storage temp.
- 2-8°C
- Löslichkeit
- Chloroform (Slightly), DMSO (Slightly), Methanol (Slightly)
- pka
- 11.90±0.46(Predicted)
- Aggregatzustand
- Solid
- Farbe
- White to Off-White
Sicherheit
N-((S)-1-(((R)-1-Hydroxy-3-Methylbutyl)aMino)-1-oxo-3-phenylpropan-2-yl)pyrazine-2-carboxaMide Chemische Eigenschaften,Einsatz,Produktion Methoden
N-((S)-1-(((R)-1-Hydroxy-3-Methylbutyl)aMino)-1-oxo-3-phenylpropan-2-yl)pyrazine-2-carboxaMide Upstream-Materialien And Downstream Produkte
Upstream-Materialien
Downstream Produkte
N-((S)-1-(((R)-1-Hydroxy-3-Methylbutyl)aMino)-1-oxo-3-phenylpropan-2-yl)pyrazine-2-carboxaMide Anbieter Lieferant Produzent Hersteller Vertrieb Händler.
Global( 63)Lieferanten
- 2-PyrazinecarboxaMide, N-[(1S)-2-[[(1R)-1-hydroxy-3-Methylbutyl]aMino]-2-oxo-1-(phenylMethyl)ethyl]-
- (R)-Hydroxy Des(boric Acid) BortezoMib
- (N-[(1R)-1-hydroxy-3-Methylbutyl]-Nα-(pyrazin-2-ylcarbonyl)-L-phenylalaninaMide
- Bortezomib Impurity 2 (SR-Isomer, Bortezomib Impurity E)
- SR-Isomer, Bortezomib Impurity E
- N-((S)-1-(((R)-1-Hydroxy-3-Methylbutyl)aMino)-1-oxo-3-phenylpropan-2-yl)pyrazine-2-carboxaMide
- BortezoMib IMpurity 2 (SR-IsoMer, EP IMpurity E)
- Bortezomib Impurity 2 (S,R-Isomer)
- Bortezomib USP Related Compoud I
- N-[(1S)-2-[[(1R)-1-Hydroxy-3-methylbutyl]amino]-2-oxo-1-(phenylmethyl)ethyl]-2-pyrazinecarboxamide
- N-[(1S)-2-[[(1R)-1-hydroxy-3-methylbutyl]amino]-2-oxo-1-(phenylmethyl)ethyl]pyrazin
- Bortezomib (1S,2R) Isomer Impurity
- Bortezomib impurity 5/Bortezomib EP Impurity E
- Bortezomib USP IMP I
- Bortezomib (EP) Impurity E
- Bortezomib USP Impurity I
- Bortezomib Related Compund I/ (S,R)-Bortezomib Hydroxyisopentyl Amide Analog (Bortezomib Hydroxy S,R-Isomer Impurity)
- (S,R)-Bortezomib Hydroxyisopentyl Amide Analog
- N-((S)-1-(((R)-1-hydroxy-3-methylbutyl)amino)-1-oxo-3-phenylpropan
- N-((S)-1-(((R)-1-hydroxy-3-methylbutyl)amino)-1-oxo-3-phenylpropan-2-yl)pyrazine-2-carboxamide? (Bortezomib Impurity）
- 289472-78-2
